Novartis heart failure drug cuts death by 37 percent: study

[riky]

Novartis heart failure drug cuts death by 37 percent: study

LOS ANGELES (Reuters) - An experimental Novartis AG drug to treat hospitalized acute heart failure patients reduced deaths by 37 percent compared with a placebo and appeared to be safe, according to data from a late stage clinical trial presented on Tuesday. The drug, serelaxin, which is a form of a human hormone that relaxes blood vessels and eases stress on the heart and other organs, is considered one of the most important medicines in the Swiss drugmaker's developmental pipeline. "With a meaningful mortality benefit, we believe Serelaxin could represent a $2. ...

Source: You are not allowed to view links. Register or Login